Grants and Contributions:
Title:
Development, production and marketing of new products based on ion exchange resins
Agreement Number:
882607
Agreement Value:
$500,000.00
Agreement Date:
Mar 1, 2017 - Nov 1, 2019
Description:
The research work consists in developing a coated tablet formula and bio-equivalent to the Canadian reference in powder form. The tablet must be stable and has olfactory-gustatory characteristics superior to that of the powder. The manufacturing process, must ensure the stability of the product in the long run.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Laval, Quebec, CA H7V 4B4
Reference Number:
172-2018-2019-Q4-882607
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
811264589
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days.
Amendment Date
Aug 9, 2019
Recipient's Legal Name:
SOBIO PHARMACEUTIQUE CANADA INC.
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: